NCT00000595View on ClinicalTrials.gov

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 1978

Study Completion Date

September 30, 1994

Conditions

Anemia (Iron-Loading)Beta-ThalassemiaHematologic DiseasesHemoglobinopathiesThalassemiaIron OverloadHemochromatosis

Interventions

DRUG

deferoxamine

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH